IP Verse

Ucb Biopharma Sprl competitive analysis

Latest publications and patents of Ucb Biopharma Sprl New

Explore the latest publications and patents granted to Ucb Biopharma Sprl, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ucb Biopharma Sprl

EP3311168
May 10, 2023Novel Tnf Structure For Use In TherapyGranted And Under Opposition
EP2515887
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of RotigotineOpposition Rejected
EP2475682
Jan 31, 2018Multivalent AntibodiesNo Opposition Filed Within Time Limit
EP2535350
Jan 24, 2018Dual Specificity Antibody FusionsNo Opposition Filed Within Time Limit
EP2922533
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of RotigotineRevoked

Latest patents of Ucb Biopharma Sprl opposed by its competitors

Explore Ucb Biopharma Sprl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3311168
May 10, 2023Novel Tnf Structure For Use In Therapy1
EP2515887
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
EP2922533
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Latest PTAB cases involving Ucb Biopharma Sprl

Discover the latest PTAB cases involving Ucb Biopharma Sprl, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ucb Biopharma Sprl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
UCB BIOPHARMA SPRL - 5 - - Non-Active
AMW32 - - Aggressive
DR H ULRICH DORRIES26 - - - Highly Aggressive
GENERICS UK212 - - - Highly Aggressive